AbCellera Biologics' Series A Round

AbCellera Biologics raised a round of funding on September 27, 2018. Investors include Data Collective.

AbCellera Biologics is a privately held company that provides technologies to biotechnology and pharmaceutical partners with the goal of discovery and development of next-generation monoclonal antibod…

Articles about AbCellera Biologics' Series A Round: